Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee backs bill to expand Medicaid access to continuous glucose monitors
Summary
Senate Bill 521 (as amended) would expand Medicaid coverage for continuous glucose monitors (CGMs) for patients with insulin‑treated diabetes and certain rare glycogen storage disease cases; clinicians testified CGMs improve outcomes and reduce hospitalization; sponsor estimated a potential cost of about $15 million if fully utilized.
Senate Bill 521, as amended, would require Medicaid to cover continuous glucose monitors (CGMs) for beneficiaries with insulin‑treated diabetes who meet frequency or hypoglycemia criteria and for individuals with certain glycogen storage diseases. Sponsor Senator Davis and clinician witnesses said the change aligns Arkansas with most other states and would…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
